AngioVac Removal of an Isolated Infected Pulmonary Valve Papillary Fibroelastoma

Jessica Joseph-Alexis; Aaron Jaffe; Jomel Patrick Jacinto; Rami Akel

doi:10.1016/j.jaccas.2020.10.008

AngioVac Removal of an Isolated Infected Pulmonary Valve Papillary Fibroelastoma

JACC Case Rep. 2020 Nov 18;2(14):2213-2216. doi: 10.1016/j.jaccas.2020.10.008.

Authors

Jessica Joseph-Alexis¹, Aaron Jaffe¹, Jomel Patrick Jacinto¹, Rami Akel¹

Affiliation

¹ HCA Healthcare/USF Morsani College of Medicine GME Programs at Regional Medical Center, Bayonet Point, Hudson, Florida.

Abstract

The AngioVac (Angiodynamics) system is indicated for the removal of right-sided venous soft thrombi and emboli. This is the first report that demonstrates the AngioVac system can be extended to the extraction of right-sided cardiac tumors, in the current case, a pulmonary valve papillary fibroelastoma infected with Streptococcus salivarius and Rothia species. (Level of Difficulty: Advanced.).

Keywords: AngioVac; MSSA, methicillin-sensitive Staphylococcus aureus; PFE, pulmonic fibroelastoma; TEE, transesophageal echocardiogram; endocarditis; infective endocarditis; papillary.

Publication types

Case Reports